A person's immune response to variants of SARS-CoV-2, the virus that causes COVID-19, depends on their previous exposure—and differences in the focus of immune responses will help scientists understand how to optimize vaccines ...
Oct 5, 2023
1
9
The journal Nature has published the results of the world's largest and most comprehensive study on the effects of common genetic variation on proteins circulating in the blood and how these associations can contribute to ...
Oct 4, 2023
0
29
An article published in Nature Communications on the pilot study carried out in Catalonia to evaluate the self-collection of biological samples reveals the high acceptability of the proposal and the key role of diagnosis ...
Oct 2, 2023
0
1
The blood-brain barrier, the body's way of shielding sensitive brain tissue from viruses, toxins and other harmful substances in the blood, can pose a problem for physicians caring for patients with suspected brain diseases ...
Sep 27, 2023
0
42
Researchers have found evidence of inherent changes to the pancreas in people with type 1 diabetes. Published recently in Scientific Reports, these new findings help explain how low blood glucose occurs in type 1 diabetes.
Sep 27, 2023
0
23
Long COVID patients have clear differences in immune and hormone function to patients without the condition, according to a new study led by the Icahn School of Medicine at Mount Sinai and Yale School of Medicine.
Sep 25, 2023
0
80
In a new study from the NIH's Environmental influences on Child Health Outcomes (ECHO) Program, higher prenatal phthalate levels were associated with a slightly increased risk of postpartum depression.
Sep 22, 2023
2
13
Children whose mothers had a higher exposure to certain phthalates during pregnancy tend to show smaller total gray matter in their brains at age 10. This is one of the main conclusions of a study led by the NYU Grossman ...
Sep 20, 2023
1
43
In a sign that exposure to certain endocrine-disrupting chemicals may be playing a role in cancers of the breast, ovary, skin and uterus, researchers have found that people who developed those cancers have significantly higher ...
Sep 18, 2023
1
129
Combination immunotherapy with the anti-PD-L1 monoclonal antibody durvalumab and other novel agents outperforms durvalumab alone in the neoadjuvant (pre-surgical) setting for early-stage non-small-cell lung cancer (NSCLC), ...
Sep 14, 2023
0
66
